[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jasper Therapeutics Inc. (JSPR)

Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Jasper Therapeutics Inc. 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 USA

https://jaspertherapeutics.com Employees: 22 P: 650-549-1400

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 26,046
Enterprise Value, $K -2,644
Shares Outstanding, K 27,997
Float, K 26,709
% Float 95.40%
Short Interest, K 2,730
Short Float 9.75%
Days to Cover 3.33
Short Volume Ratio 0.23
% of Insider Shareholders 4.60%
% of Institutional Shareholders 79.85%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -75,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,100 K
EBIT, $ -83,890 K
EBITDA, $ -82,830 K

Growth:

1-Year Return -82.71%
3-Year Return -93.80%
5-Year Return -99.06%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 03/30/26
Next Earnings Date 05/11/26 [--]
Earnings Per Share ttm -4.60
EPS Growth vs. Prev Qtr 71.68%
EPS Growth vs. Prev Year 80.25%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/04/24

JSPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -372.18%
Return-on-Assets % -153.67%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.31
Book Value/Share 0.15
Interest Coverage -2.65
60-Month Beta 3.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.